MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$32,711K
EPS
-$0.47
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Research and development
20,090
22,195
22,255
26,755*
General and administrative
13,924
9,773
8,930
6,569*
Total operating expenses
34,014
31,968
31,185
33,324
Loss from operations
-34,014
-31,968
-31,185
-33,324*
Interest income
2,401
2,663
2,740
2,727*
Interest expense
843
745
732
720*
Loss on extinguishment of debt
-
-
-488
0*
Other expenses, net
-45
-177
-87
271*
Total other income, net
1,513
1,741
1,433
2,278*
Net loss before income taxes
-32,501
-30,227
-29,752
-31,046*
Provision for income taxes
0
0
0
-717*
Net loss
-32,501
-30,227
-29,752
-30,329*
Unrealized loss (gain) on available-for-sale investments
-210
-299
46
1,251*
Total comprehensive loss
-32,711
-30,526
-29,706
-29,078
Basic EPS
-0.47
-0.43
0.44
-0.569
Diluted EPS
-0.47
-0.43
0.44
-0.569
Basic Average Shares
69,734,610
69,724,761
67,263,234
51,141,247
Diluted Average Shares
69,734,610
69,724,761
67,263,234
51,141,247
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ENGN Income Statement Sankey Diagram
Sankey diagram visualizing ENGN income statement for the period
Total comprehensive
loss
-$32,711K
(-11.91%↓ Y/Y)
Net loss
-$32,501K
(-12.11%↓ Y/Y)
Unrealized loss (gain) on
available-for-sale investments
-$210K
(12.50%↑ Y/Y)
Interest income
$2,401K
(7.52%↑ Y/Y)
Net loss before
income taxes
-$32,501K
(-13.04%↓ Y/Y)
Total other income,
net
$1,513K
(26.61%↑ Y/Y)
Interest expense
$843K
(11.21%↑ Y/Y)
Other expenses, net
-$45K
(83.93%↑ Y/Y)
Loss from operations
-$34,014K
(-13.58%↓ Y/Y)
Total operating
expenses
$34,014K
(13.58%↑ Y/Y)
Research and development
$20,090K
(-11.01%↓ Y/Y)
General and
administrative
$13,924K
(88.88%↑ Y/Y)
Buy us a coffee
enGene Therapeutics Inc. (ENGN)
enGene Therapeutics Inc. (ENGN)